Sunday, 23 November 2025

Week 537 Review - A dreadful week for my SIPP.

A pretty dreadful week for most of the portfolio, with the rare situation where the SIPP accounted for the majority of the week's losses while the ISA was pretty flat. The deficit between cost and value widened by £1,472 to £147,060 and the deficit between injection and value widened to £66,471. Total portfolio value dropped to £113,097.

This week's biggest loser was IPX:Impax Asset Management which dropped a massive 10%. There was no news, so I don't know why there was such a big fall. It meant my recent purchase went from being 1% in profit to 9% in the red, although that's better than my initial purchase which is down by 62%.

INVP:Investec also went from profitable into loss, dropping 9% to go 4% down. This was after a half yearly trading update that wasn't well received.

FDM:FDM Group dropped 8% which could have been profit taking after the big rise last week.

IHP:Integrafin dropped 8% for no obvious reason, making me contemplate buying more.

PBX:Probiotix Health have been drifting for a while on no news and fell 7% this week.

ASHM:Ashmore Group dropped 6% and continue to plummet since the end of October when I thought they may be returning to break even.

AFC:AFC Energy continue to yo-yo and dropped 5% this week, which is less than usual.

N91:Ninety One dropped 5% which was probably reaction to the half-yearly report, but it looked OK to me.

PAF:Pan African Resources dropped 5% as the price of gold fell a little. My holding is still up by 196% though.

POLR:Polar Capital dropped 5% for no reason, which dented my potential profits given I've bought quite a lot recently.

TLOU:Tlou Energy went up by 5%, but it's just the usual weekly ups and downs.

ALU:Alumasc Group got a bit hammered recently but are slowly crawling back, increasing 6% this week.

SBTX:SkinBioTherapeutics has mysteriously risen 10% this week. There are rumours of an imminent product launch so it could be tied in with that, although I've seen no evidence to substantiate the rumours.

AMP:Ampeak Energy went up 12% after confirmation that funding has been received for their battery storage project.

FXPO:Ferrexpo went up 16% which may have been a reaction to the possible Ukraine peace plan. However, now that's been revealed as just a Russian wish-list they will no doubt drop again next week. For now it's taken them to 88% down so below 90% and I have to start reporting on them again.

Share of the week is GAW:Games Workshop which zoomed up 16% after a great trading statement and improved guidance from analysts. My holding went to to 101% up, joining PAF:Pan African Resources as my only shares above 100% up.

Here's the ISA and shares portfolio after week 17 of year 11.

Weekly Change
Cash£90.86    +£0.01
Portfolio cost£116,758.09+£0
Portfolio sell value
(bid price-commission)
£36,046.92(-69.1%)-£90.80
Potential profits£140.24-£31.59
Yr 11 Dividends£25.32
+£0
Yr 11 Interest£0.74            +£0
Yr 11 Profit from sales£487.56+£0
Yr 11 proj avg monthly profit£122.82(1.7%)-£7.68
Total Dividends£12,513.39+£0
Total Interest£9.31    +£0
Total Profit from sales£18,047.83+£0
Average monthly cash profit£241.86(3.3%)-£0.46
(Sold stocks profit + Dividends
- Fees / Months)

A virtually flat week as OPTI:Optibiotix increased 4% and SBTX:SkinBioTherapeutics climbed 10% while JLP:Jubilee Metals dropped 3% and PBX:Probiotix Health dropped 7% so the changes evened themselves out, but in the red overall. Potential profits dropped slightly thanks to a 3% fall in AMRQ:Amaroq.


This has been pretty flat for some time now.


Right on the trend line.


The SIPP looks like this after week 521 overall and week 1 of year 11.




Weekly Change
Cash£1,091.18
+£63.90
Portfolio cost£142,217.38
+£0
Portfolio sell value
(bid price - commission)
£75,868.22(-46.7%)-£1,381.53
Potential profits£7,315.51
-£512.98
Yr 11 Dividends£9.35
+£9.35
Yr 11 Interest£0
+£0
Yr 11 Profit from sales£0
+£0
Yr 11 proj avg monthly profit£40.50(0.5%)+£40.50
Total Dividends£18,229.55
+£9.35
Total Interest£20.70
+£0
Total Profit from sales£24,666.51
+£0
Average monthly cash profit£343.47(4.5%)-£0.58

This portfolio was hammered, as it was mainly magic formula shares that took big drops. Potential profit fell £512 mainly due to big drops in AMRQ:Amaroq, N91:Ninety One, PAF:Pan African Resources, POLR:Polar Capital and PRU:Prudential. GAW:Games Workshop clawed some of the losses back else it would have been worse.

Cash went up thanks to a tax rebate and £9 dividends from GAW:Games Workshop, and that means in week 1 of  year 11the projected profit is £40 a month, which I may be able to maintain without sales as more dividends come in.


Although a bad week, this has been fairly flat lately.


This week's drop takes us just below the trend line - again.


Still just above the trend line.

We had the JLP:Jubilee Metals production update and the price dropped, so there is very little hope of a revival any time soon. There is an update on joint venture partners due before the end of November, so still a glimmer of hope of something happening before Christmas, but no guarantee it will be positive.

OPTI:Optibiotix still haven't given the promised 2nd generation products update. There was news of a new Slimbiome contract, but a rather puny 0.3p rise was all we got out of it. This is another one where I fear there is little hope of improvement before Christmas.

The American market reversed declines on Friday after the UK market had closed, which seems to happen quite often on Fridays. Hopefully that increase will be reflected in our market on Monday morning.

No comments:

Post a Comment